# FDA Inspection 1117911 - Octapharma Plasma, Inc. - January 31, 2020

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/3fc4f930-9b90-405f-a48f-07f1ab7e91cd
Source feed: FDA_Inspections

> FDA Inspection 1117911 for Octapharma Plasma, Inc. on January 31, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1117911
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2020-01-31
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 999141 - 2017-01-25](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/a5b3c089-4b1b-45e1-a475-39935dfe3999)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/1a8461b0-cebc-4d28-b237-82c75cdf5e3d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d